Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. US FDA label
- clioquinol no separate page
Use: INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of Gentamicin Sulfate in 0.9% Sodium Chloride Injection and other antibacterial drugs, Gentamicin Sulfate in 0.9%… US FDA label
Kidney dosing: Gentamicin (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Normal kidney function: 3 mg/kg/day in 3 doses every 8 hours; up to 5 mg/kg/day for life-threatening infection, reduced as soon as possible. Obese patients: dose by lean body mass. Measure peaks (4 to 6 mcg/mL) and troughs (label). Alternative (not in label): extended-interval dosing, e.g., 7 mg/kg with interval by CrCl (≥60: every 24 h; 40–59: every 36 h; 20–39: every 48 h) and a single-level nomogram (Nicolau 1995). Not validated below CrCl 20 or on dialysis: use the label method with levels.
- CrCl 30–59 mL/min
- After the usual first dose, either extend the interval (hours = serum creatinine in mg/dL × 8) or keep 8-hourly doses reduced by the label's serum creatinine table (Table 4) or by dividing the normal dose by serum creatinine. Avoid prolonged peaks above 12 mcg/mL and troughs above 2 mcg/mL; measure levels (label). Table 4 examples: CrCl about 40–45 (SCr 2–2.2): 50%; 30–35 (SCr 2.6–3): 35% of the usual dose every 8 hours. Alternative (not in label): extended-interval dosing, e.g., 7 mg/kg with interval by CrCl (≥60: every 24 h; 40–59: every 36 h; 20–39: every 48 h) and a single-level nomogram (Nicolau 1995). Not validated below CrCl 20 or on dialysis: use the label method with levels. In AKI, creatinine lags; the label warns that deteriorating kidney function needs a greater reduction than these tables.
- CrCl 15–29 mL/min
- After the usual first dose, either extend the interval (hours = serum creatinine in mg/dL × 8) or keep 8-hourly doses reduced by the label's serum creatinine table (Table 4) or by dividing the normal dose by serum creatinine. Avoid prolonged peaks above 12 mcg/mL and troughs above 2 mcg/mL; measure levels (label). Table 4 example: CrCl about 20–25: 25%; 15–20: 20% of the usual dose every 8 hours. Alternative (not in label): extended-interval dosing, e.g., 7 mg/kg with interval by CrCl (≥60: every 24 h; 40–59: every 36 h; 20–39: every 48 h) and a single-level nomogram (Nicolau 1995). Not validated below CrCl 20 or on dialysis: use the label method with levels. In AKI, creatinine lags; the label warns that deteriorating kidney function needs a greater reduction than these tables.
- CrCl <15 mL/min (not on dialysis)
- After the usual first dose, either extend the interval (hours = serum creatinine in mg/dL × 8) or keep 8-hourly doses reduced by the label's serum creatinine table (Table 4) or by dividing the normal dose by serum creatinine. Avoid prolonged peaks above 12 mcg/mL and troughs above 2 mcg/mL; measure levels (label). Table 4: CrCl about 10–15: 15%; under 10: 10% of the usual dose every 8 hours. Specialist input. In AKI, creatinine lags; the label warns that deteriorating kidney function needs a greater reduction than these tables.
- Hemodialysis (intermittent)
- 1 to 1.7 mg/kg at the end of each dialysis, depending on severity of infection; an 8-hour hemodialysis lowers levels by about 50% (label). Check levels.
- Peritoneal dialysis
- No PD dose in label; removal by peritoneal dialysis is much slower than by hemodialysis. For PD-associated peritonitis (ISPD 2022): 0.6 mg/kg intraperitoneally once daily, intermittent (in one exchange daily with a dwell of at least 6 hours); continuous dosing is not advised. Check levels; specialist input.
- CRRT
- No data in label, and gentamicin is not in the Li 2020 CRRT table. Level-guided dosing with specialist input.
- Dialyzable? Yes by hemodialysis (about 50% over 8 hours; label); much less by peritoneal dialysis. Protein binding 0% to 30%.
- Monitoring Peak and trough levels; serum creatinine before and during therapy; urinalysis; hearing and vestibular function; magnesium, calcium and potassium (wasting, Fanconi-like syndrome reported). Avoid other nephrotoxic drugs and potent diuretics.
From the Gentamicin monograph (renalcarematters.com, reviewed).
Use: INDICATIONS AND USAGE: Mycozyl AL™ is effective in the treatment of most skin infections such as athlete's foot (tinea pedis) and ringworm (tinea corporis). US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per g cream: 10 mg/10 mg/1 mg/500 mcg
- Per gram ointment: 500 mcg/1 mg/10 mg/10 mg
- Cream: 10 mg/10 mg/1 mg/500 mcg
- Per g topical cream: 500 mcg/1 mg/10 mg/10 mg
- Per gram cream: 10 mg/10 mg/1 mg/500 mcg
Registered products in the Philippines
7 products registered with the Food and Drug Administration (FDA) Philippines list Betamethasone + Clioquinol + Gentamicin + Tolnaftate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products7
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Polyderm 4Tolnaftate + Clioquinol + Gentamicin Sulfate + Betamethasone Valerate | 10 mg/10 mg/1 mg/500 mcg per gram CreamAluminum Tube x 3 g, 5 g and 10 g (Box of 1's); Aluminum Tube x 3 g, 5 g and 10 g (Box of 6's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-7740 | Jul 31, 2028 | |
QuadmixBetamethasone (as dipropionate) + Gentamicin (as Sulfate) + Tolnaftate + Clioquinol | 500 mcg/1 mg/10 mg/10 mg per g Topical CreamAluminum Collapsible Tube X 5 g (Box of 1’s) | Rx | Yash Medicare Private LimitedIndia | Aglobal Care, Inc.Trader: Antila Lifesciences Pvt. Ltd. | DR-XY46784 | Dec 20, 2029 | |
QuadrotopicTolnaftate + Clioquinol + Gentamicin (as sulfate) + Betamethasone (as valerate) | 10 mg/ 10 mg/ 1 mg/ 500 mcg CreamAluminum Collapsible Tube x 5g and 3.5g Not Applicable | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Vendiz Pharmaceuticals Inc. | DRP-11254 | Sep 16, 2030 | |
QuadrotopicTolnaftate/ Clioquinol/ Gentamicin (as sulfate)/ Betamethasone (as valerate) | 10 mg/ 10 mg/ 1 mg/ 500 mcg per g CreamHDPE Plastic Jar x 500 g | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Vendiz Pharmaceuticals Inc. | DR-XY18727 | Jul 9, 2027 | |
QuadrotopicTolnaftate/ Clioquinol/ Gentamicin (as sulfate)/ Betamethasone (as valerate) | 10 mg/ 10 mg/ 1 mg/ 500 mcg per g CreamHDPE Plastic Jar x 500 g | Rx | Ashford Pharmaceutical Laboratories, Inc.Philippines | Trader: Vendiz Pharmaceuticals Inc. | DRP-12783 | Jul 9, 2027 | |
QuadrovicBetamethasone (as Valerate) + Gentamicin (as Sulfate) + Tolnaftate + Clioquinol | 500 mcg/1 mg/10 mg/10 mg per gram OintmentAluminum Tube x 5 g (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Advancetek Pharma and Medical Supplies Co.Trader: Randril International Co., Inc. | DRP-7664-01 | Aug 26, 2029 | |
QuatrodermBetamethasone (as Valerate) + Gentamicin (as Sulfate) + Tolnaftate + Clioquinol | 500 mcg/1 mg/10 mg/10 mg per gram OintmentAluminum Tube x 5 g (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Aldril Pharmaceuticals, Inc.Trader: Randril Internation Co., Inc. | DRP-7664 | Aug 26, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .